Effects of trans-10, cis-12 conjugated linoleic acid on the expression of uncoupling proteins in hamsters fed an atherogenic diet.
It is known that conjugated linoleic acid (CLA) feeding decreases body adiposity but the mechanisms involved are not clear. The aim of this study was to analyse whether alterations in uncoupling protein (UCP) expression in white and brown adipose tissues (WAT and BAT, respectively) and in skeletal muscle may be responsible for the effect of trans-10, cis-12 CLA on the size of body fat depots in hamsters. Animals were divided into three groups and fed an atherogenic diet with different amounts of trans-10, cis-12 CLA (0 control, 0.5, or 1 g/100 g diet) for 6 weeks. CLA feeding reduced adipose depot weights, but had no effect on body weight. Leptin mRNA expression decreased in both subcutaneous and perirenal WAT depots, in accordance with lower adiposity, whereas resistin mRNA expression was not changed. Animals fed CLA had lower UCP1 mRNA levels in BAT (both doses of CLA) and in perirenal WAT (the low dose), and lower UCP3 mRNA levels in subcutaneous WAT (the high dose). UCP2 mRNA expression in WAT was not significantly affected by CLA feeding. Animals fed the high dose of CLA showed increased UCP3 and carnitine palmitoyl transferase-I (CPT-I) mRNA expression levels in skeletal muscle. In summary, induction of UCP1 or UCP2 in WAT and BAT is not likely to be responsible for the fat-reduction action of CLA, but the increased expression of UCP3 in skeletal muscle, together with a higher expression of CPT-I, may explain the previously reported effects of dietary CLA in lowering adiposity and increasing fatty acid oxidation by skeletal muscle.
Ribot
Joan
J
Bioquímica, Biología Molecular, Nutrición y Biotecnología (Nutrigenómica), Universitat de les Illes Balears (UIB), Cra. Valldemossa, km 7.5, 07122 Palma de Mallorca, Spain.
Portillo
Maria P
MP
Picó
Catalina
C
Macarulla
M Teresa
MT
Palou
Andreu
A
D000273:Adipose Tissue / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D015152:Blotting, Northern / Q000379:methods; D001835:Body Weight / Q000187:drug effects; D006224:Cricetinae; D004036:Diet, Atherogenic; D019587:Dietary Supplements; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D007473:Ion Channels / Q000096:biosynthesis* / Q000235:genetics; D020738:Leptin / Q000096:biosynthesis / Q000235:genetics; D044243:Linoleic Acids, Conjugated / Q000494:pharmacology*; D008297:Male; D008647:Mesocricetus; D024101:Mitochondrial Proteins / Q000096:biosynthesis* / Q000235:genetics; D018482:Muscle, Skeletal / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D052243:Resistin / Q000096:biosynthesis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D000071256:Uncoupling Protein 1
D007473:Ion Channels; D020738:Leptin; D044243:Linoleic Acids, Conjugated; D024101:Mitochondrial Proteins; D012333:RNA, Messenger; D052243:Resistin; D000071256:Uncoupling Protein 1; C496197:trans-10,cis-12-conjugated linoleic acid